# Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

> **NCT03500653** · NA · UNKNOWN · sponsor: **Henit Yanai** · enrollment: 100 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Curcumin
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03500653
- **Lead sponsor:** Henit Yanai
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-09
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03500653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03500653, "Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03500653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*